Cal 25 and NSE as Tumor Markers for Desmoplastic Small Round-Cell Tumors
Author Information
Author(s): K Fizazi, F Farhat, C Theodore, O Rixe, A Le Cesne, E Comoy, T Le Chevalier
Primary Institution: Institut Gustave-Roussy
Hypothesis
Are Cal 25 and neuron-specific enolase (NSE) effective tumor markers for monitoring intra-abdominal desmoplastic small round-cell tumors?
Conclusion
Cal 25 and NSE are frequently elevated in patients with intra-abdominal desmoplastic small round-cell tumors but are not reliable for monitoring disease progression.
Supporting Evidence
- Cal 25 was initially high in six of the seven patients (86%) with a median value of 200 U ml-1.
- NSE was elevated before therapy in three of the five patients (60%) for whom assay results were available.
- Cal 25 normalized in five out of six cases during chemotherapy.
- NSE always normalized during chemotherapy.
- At progression, Cal 25 was elevated in two out of four cases several weeks before clinical relapse.
Takeaway
Doctors looked at two blood tests, Cal 25 and NSE, to see if they could help track a rare type of cancer in kids and young adults. They found that while these tests often showed high levels, they didn't really help in knowing how the cancer was doing.
Methodology
Seven patients were screened for various tumor markers before treatment, and their levels were monitored during chemotherapy.
Limitations
The study involved a small sample size and lacked a control group.
Participant Demographics
Four males and three females, with a mean age of 22 years (range 15-30 years).
Want to read the original?
Access the complete publication on the publisher's website